Takeda and Prana to research neurodegeneration treatment for Parkinson's disease

Takeda Pharmaceuticals International has entered a new research collaboration to study the ability of Prana Biotechnology ’s investigational movement disorders compound, PBT434, to slow down or prevent neurodegeneration of the gastrointestinal system …
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news